You are here: Industry Insights > antiviral

News List

Based on the Current Status of Drug Research and Development Targeting the Pathogenesis of Influenza (Part 2) Xiaomichong
July 12, 2024
Influenza is an acute respiratory infectious disease caused by the influenza virus.
UK government launches search for at-home COVID-19 treatments pharmatimes
April 22, 2021
The UK government has launched a new Antivirals Taskforce in a bid to identify promising home treatments for people who have been exposed to COVID-19.
Potential antiviral treatment for COVID-19 identified expresspharma
February 05, 2021
The drug is also able to prevent a virus from making new copies of itself in cells for at least 48 hours after a single 30-minute exposure.
Remdesivir likely to be highly effective antiviral against SARS-CoV-2 worldpharmanews
December 16, 2020
The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists.
COVID-19 drug development could benefit from approach used against flu worldpharmanews
June 04, 2020
A new study from researchers at The University of Texas at Austin has found that some antivirals are useful for more than helping sick people get better.
USP Offers Support for COVID-19 Antiviral/Vax Developers contractpharma
March 20, 2020
Aims to help developers ensure quality of their materials as they scale up manufacturing to bring products into clinical development.
Scientists propose method of producing water-soluble fullerene compounds europeanpharmaceuticalreview
March 19, 2020
A new single-step technique has been developed which could enable the synthesis of water-soluble fullerene compounds for use in pharma.
Enanta Pharmaceuticals explores Covid-19 treatments pharmaceutical-technology
March 17, 2020
Biotechnology firm Enanta Pharmaceuticals has launched efforts to identify direct-acting antiviral drug candidates to treat Covid-19 coronavirus infection.
Vial switch improves life-saving antiviral drug cphi-online
April 26, 2019
Legacy Pharmaceuticals uses SCHOTT Type I Plus vials to overcome a leaching issue.
Antiviral Treatments Reduce Cancer Risk for HIV Patients drugs
June 12, 2018
People with HIV are at increased risk for both AIDS-related cancers (Kaposi sarcoma, non-Hodgkin lymphoma or invasive cervical cancer) and non-AIDS-related cancers (lung and larynx cancer, melanoma and leukemia).

Previous page 1 2 Next page